Skip to content

Reprogramming is the

next leap forward in cancer immunotherapy

ABOUT ASGARD THERAPEUTICS

Co-founder and CEO Cristiana Pires speaks about Asgard Therapeutics and explains how TrojanDC works.

An important hallmark of cancer is the ability to evade the immune system. Asgard Therapeutics has the ambitious goal to establish dendritic cell reprogramming as an entirely new approach to unleash the immune system against cancer.

Learn more

OUR TEAM

Asgard was created by some of the brightest researchers in the cell reprogramming field. In the end, we hope our work will make a measurable impact in patients’ life. Meet our team